Clinical Trial: Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: Pilot Study to Identify Radiogenomic Biomarkers to Predict Early Treatment Response to Androgen Deprivation Therapy and Radiation Therapy in High Risk Prostate Cancer
Brief Summary:
The purpose of this study is to evaluate the imaging and gene expression biomarkers in prostate cancer.Participants have high-risk prostate cancer and have indicated they will undergo external beam radiation therapy, brachytherapy, and androgen deprivation therapy (EBRT+BTX+ADT).Participants can expect to be in this study for up to 5 years.
Read more